{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:34:01Z","timestamp":1793223241808,"version":"4.5.0"},"reference-count":57,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Anti-M\u00fcllerian hormone (AMH) measured in adolescence as biomarker for prediction of adult polycystic ovary syndrome (PCOS) is doubtful but not substantiated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate whether serum AMH levels and other PCOS-associated features in adolescence can predict the presence of PCOS in adulthood.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design and Setting<\/jats:title>\n                  <jats:p>A long-term follow-up study based on a unique adolescent study on menstrual irregularities performed between 1990 and 1997.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants and interventions<\/jats:title>\n                  <jats:p>AMH was assayed in 271 adolescent girls. Data on PCOS features were combined with AMH levels. In 160 of the 271 (59%) participants, we collected information in adulthood about their menstrual cycle pattern and presence of PCOS (features) by questionnaire 2 decades after the initial study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>AMH was higher in adolescent girls with oligomenorrhea compared with girls with regular cycles, median (interquartile range): 4.6 (3.1-7.5) versus 2.6 (1.7-3.8) \u03bcg\/L (P\u2005&amp;lt;\u20050.001). Women with PCOS in adulthood had a higher median adolescent AMH of 6.0 compared with 2.5 \u03bcg\/L in the non-PCOS group (P\u2005&amp;lt;\u20050.001). AMH at adolescence showed an area under the receiver operating characteristic curve for PCOS in adulthood of 0.78. In adolescent girls with oligomenorrhea the proportion developing PCOS in adulthood was 22.5% (95% CI, 12.4-37.4) against 5.1% (95% CI, 2.1-12.0) in girls with a regular cycle (P\u2005=\u20050.005). Given adolescent oligomenorrhea, adding high AMH as factor to predict adult PCOS or adult oligomenorrhea was of no value.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Adolescent AMH either alone or adjuvant to adolescent oligomenorrhea does not contribute as prognostic marker for PCOS in adulthood. Therefore, we do not recommend routine its use in clinical practice.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa949","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T15:39:32Z","timestamp":1608651572000},"page":"e1084-e1095","source":"Crossref","is-referenced-by-count":18,"title":["Anti-M\u00fcllerian Hormone Levels in Adolescence in Relation to Long-term Follow-up for Presence of Polycystic Ovary Syndrome"],"prefix":"10.1210","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2149-2115","authenticated-orcid":false,"given":"Mirte R","family":"Caanen","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine, Amsterdam UMC, Vrije Universiteit, HV Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9448-8921","authenticated-orcid":false,"given":"Henrike E","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Amsterdam UMC, Vrije Universiteit, HV Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M","family":"van de Ven","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit, HV Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M F M","family":"J\u00fcttner","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Amsterdam UMC, Vrije Universiteit, HV Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop S E","family":"Laven","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, Erasmus University Medical Center, CA Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel H A","family":"van Hooff","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Sint Franciscus Hospital, PM Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3947-5129","authenticated-orcid":false,"given":"Cornelis B","family":"Lambalk","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Amsterdam UMC, Vrije Universiteit, HV Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,12,22]]},"reference":[{"issue":"3","key":"2021122117414331900_CIT0001","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update."},{"issue":"2","key":"2021122117414331900_CIT0002","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deg042","article-title":"Serum anti-M\u00fcllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod."},{"issue":"3","key":"2021122117414331900_CIT0003","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/jc.2008-1818","article-title":"Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure","volume":"94","author":"Knauff","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2021122117414331900_CIT0004","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-M\u00fcllerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"van Rooij","year":"2002","journal-title":"Hum Reprod."},{"issue":"1-2","key":"2021122117414331900_CIT0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mce.2004.09.008","article-title":"Anti-M\u00fcllerian hormone and folliculogenesis","volume":"234","author":"Visser","year":"2005","journal-title":"Mol Cell Endocrinol."},{"issue":"1","key":"2021122117414331900_CIT0006","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0015-0282(01)02944-2","article-title":"Relationship between serum m\u00fcllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women","volume":"77","author":"Cook","year":"2002","journal-title":"Fertil Steril."},{"issue":"1","key":"2021122117414331900_CIT0007","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-M\u00fcllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021122117414331900_CIT0008","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.fertnstert.2011.04.003","article-title":"Antim\u00fcllerian hormone and polycystic ovary syndrome","volume":"96","author":"Lin","year":"2011","journal-title":"Fertil Steril."},{"issue":"12","key":"2021122117414331900_CIT0009","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021122117414331900_CIT0010","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1210\/jc.2009-2106","article-title":"Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism","volume":"95","author":"Park","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122117414331900_CIT0011","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.fertnstert.2009.11.002","article-title":"Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)","volume":"94","author":"Hart","year":"2010","journal-title":"Fertil Steril."},{"issue":"17-18","key":"2021122117414331900_CIT0012","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00508-010-1426-x","article-title":"Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome","volume":"122","author":"Li","year":"2010","journal-title":"Wien Klin Wochenschr."},{"issue":"10","key":"2021122117414331900_CIT0013","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/humrep\/deu182","article-title":"Anti-M\u00fcllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study","volume":"29","author":"Pinola","year":"2014","journal-title":"Hum Reprod."},{"issue":"5","key":"2021122117414331900_CIT0014","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0002-9378(66)90398-X","article-title":"The prognosis for adolescents with menstrual abnormalities","volume":"94","author":"Southam","year":"1966","journal-title":"Am J Obstet Gynecol."},{"issue":"6","key":"2021122117414331900_CIT0015","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021122117414331900_CIT0016","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/humrep\/det469","article-title":"The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone","volume":"29","author":"Lauritsen","year":"2014","journal-title":"Hum Reprod."},{"issue":"7","key":"2021122117414331900_CIT0017","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.tem.2019.04.006","article-title":"Anti-M\u00fcllerian hormone in PCOS: a review informing international guidelines","volume":"30","author":"Teede","year":"2019","journal-title":"Trends Endocrinol Metab."},{"issue":"1","key":"2021122117414331900_CIT0018","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group.","year":"2004","journal-title":"Hum Reprod."},{"issue":"6","key":"2021122117414331900_CIT0019","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000479371","article-title":"An International Consortium Update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence","volume":"88","author":"Ib\u00e1\u00f1ez","year":"2017","journal-title":"Horm Res Paediatr."},{"issue":"8","key":"2021122117414331900_CIT0020","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.steroids.2013.04.011","article-title":"Diagnosis of adolescent polycystic ovary syndrome","volume":"78","author":"Hardy","year":"2013","journal-title":"Steroids."},{"issue":"2","key":"2021122117414331900_CIT0021","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jadohealth.2008.05.004","article-title":"Whither PCOS? The challenges of establishing hyperandrogenism in adolescent girls","volume":"43","author":"Biro","year":"2008","journal-title":"J Adolesc Health."},{"issue":"4","key":"2021122117414331900_CIT0022","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MOP.0000000000000778","article-title":"The diagnosis and treatment of PCOS in adolescents: an update","volume":"31","author":"Witchel","year":"2019","journal-title":"Curr Opin Pediatr."},{"issue":"1","key":"2021122117414331900_CIT0023","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpag.2009.04.004","article-title":"Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome","volume":"23","author":"Bekx","year":"2010","journal-title":"J Pediatr Adolesc Gynecol."},{"issue":"8","key":"2021122117414331900_CIT0024","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/humrep\/13.8.2252","article-title":"Relationship of the menstrual cycle pattern in 14-17 year old old adolescents with gynaecological age, body mass index and historical parameters","volume":"13","author":"van Hooff","year":"1998","journal-title":"Hum Reprod."},{"issue":"2","key":"2021122117414331900_CIT0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/humrep\/deh079","article-title":"Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years","volume":"19","author":"van Hooff","year":"2004","journal-title":"Hum Reprod."},{"issue":"5","key":"2021122117414331900_CIT0026","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2021122117414331900_CIT0027","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update."},{"issue":"9","key":"2021122117414331900_CIT0028","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/humrep\/14.9.2223","article-title":"Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents","volume":"14","author":"van Hooff","year":"1999","journal-title":"Hum Reprod."},{"issue":"4","key":"2021122117414331900_CIT0029","first-page":"1394","article-title":"Insulin, androgen, and gonadotropin concentrations, body mass index, and waist to hip ratio in the first years after menarche in girls with regular menstrual cycles, irregular menstrual cycles, or oligomenorrhea","volume":"85","author":"van Hooff","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021122117414331900_CIT0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0015-0282(00)00584-7","article-title":"Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin","volume":"74","author":"van Hooff","year":"2000","journal-title":"Fertil Steril."},{"key":"2021122117414331900_CIT0031","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122117414331900_CIT0032","first-page":"520","article-title":"Classification of acne","volume":"17","author":"Kligman","year":"1976","journal-title":"Cutis."},{"issue":"8","key":"2021122117414331900_CIT0033","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/humrep\/dey229","article-title":"Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve","volume":"33","author":"van den Berg","year":"2018","journal-title":"Hum Reprod."},{"issue":"6543","key":"2021122117414331900_CIT0034","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.293.6543.355","article-title":"Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism","volume":"293","author":"Adams","year":"1986","journal-title":"Br Med J (Clin Res Ed)."},{"issue":"10","key":"2021122117414331900_CIT0035","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/aje\/kwi120","article-title":"Validity of self-reported causes of subfertility","volume":"161","author":"de Boer","year":"2005","journal-title":"Am J Epidemiol."},{"issue":"12","key":"2021122117414331900_CIT0036","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1093\/humrep\/der322","article-title":"Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort","volume":"26","author":"van Leeuwen","year":"2011","journal-title":"Hum Reprod."},{"issue":"10","key":"2021122117414331900_CIT0037","doi-asserted-by":"crossref","first-page":"e3688","DOI":"10.1210\/clinem\/dgz264","article-title":"Screening for androgen excess in women: accuracy of self-reported excess body hair growth and menstrual dysfunction","author":"Chan","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2021122117414331900_CIT0038","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1093\/humrep\/deu200","article-title":"Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study","volume":"29","author":"West","year":"2014","journal-title":"Hum Reprod."},{"issue":"4","key":"2021122117414331900_CIT0039","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1210\/jc.2018-00570","article-title":"Self-reported polycystic ovary syndrome is associated with hypertension: a Northern Finland birth cohort 1966 study","volume":"104","author":"Ollila","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122117414331900_CIT0040","article-title":"Supplementary Material","volume-title":"Figshare.","author":"Caanen","year":"2020"},{"issue":"9","key":"2021122117414331900_CIT0041","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod."},{"issue":"6","key":"2021122117414331900_CIT0042","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.rbmo.2012.02.023","article-title":"Intra-cycle fluctuations of anti-M\u00fcllerian hormone in normal women with a regular cycle: a re-analysis","volume":"24","author":"Overbeek","year":"2012","journal-title":"Reprod Biomed Online."},{"issue":"12","key":"2021122117414331900_CIT0043","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod."},{"issue":"6","key":"2021122117414331900_CIT0044","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/humupd\/dmy022","article-title":"Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Skiba","year":"2018","journal-title":"Hum Reprod Update."},{"issue":"6","key":"2021122117414331900_CIT0045","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.fertnstert.2017.04.011","article-title":"Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome","volume":"107","author":"Dokras","year":"2017","journal-title":"Fertil Steril."},{"issue":"6","key":"2021122117414331900_CIT0046","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000446111","article-title":"Do the Anti-M\u00fcllerian hormone levels of adolescents with polycystic ovary syndrome, those who are at risk for developing polycystic ovary syndrome, and those who exhibit isolated oligomenorrhea differ from those of adolescents with normal menstrual cycles?","volume":"85","author":"Savas-Erdeve","year":"2016","journal-title":"Horm Res Paediatr."},{"issue":"7","key":"2021122117414331900_CIT0047","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/humrep\/deh850","article-title":"Serum anti-M\u00fcllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome","volume":"20","author":"Piltonen","year":"2005","journal-title":"Hum Reprod."},{"issue":"8","key":"2021122117414331900_CIT0048","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/09513590.2015.1025380","article-title":"Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents","volume":"31","author":"Villarroel","year":"2015","journal-title":"Gynecol Endocrinol."},{"issue":"3","key":"2021122117414331900_CIT0049","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","article-title":"Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome","volume":"91","author":"Pigny","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2021122117414331900_CIT0050","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1093\/humrep\/des213","article-title":"Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?","volume":"27","author":"Eilertsen","year":"2012","journal-title":"Hum Reprod."},{"issue":"10","key":"2021122117414331900_CIT0051","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/humrep\/der223","article-title":"Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone","volume":"26","author":"Villarroel","year":"2011","journal-title":"Hum Reprod."},{"issue":"9","key":"2021122117414331900_CIT0052","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/humrep\/deh373","article-title":"Changes in anti-M\u00fcllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility","volume":"19","author":"Mulders","year":"2004","journal-title":"Hum Reprod."},{"issue":"12","key":"2021122117414331900_CIT0053","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1093\/humrep\/deq273","article-title":"A very large proportion of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed?","volume":"25","author":"Kristensen","year":"2010","journal-title":"Hum Reprod."},{"issue":"6","key":"2021122117414331900_CIT0054","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000481532","article-title":"New diagnostic criteria of polycystic ovarian morphology for adolescents: impact on prevalence and hormonal profile","volume":"88","author":"Merino","year":"2017","journal-title":"Horm Res Paediatr."},{"issue":"1","key":"2021122117414331900_CIT0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/jc.2002-020982","article-title":"Hormonal profile of women with self-reported symptoms of oligomenorrhea and\/or hirsutism: Northern Finland birth cohort 1966 study","volume":"88","author":"Taponen","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122117414331900_CIT0056","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/humrep\/deh214","article-title":"Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and\/or hirsutism: Northern Finland Birth Cohort 1966 Study","volume":"19","author":"Taponen","year":"2004","journal-title":"Hum Reprod."},{"issue":"2","key":"2021122117414331900_CIT0057","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ijc.30441","article-title":"Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study","volume":"140","author":"Harris","year":"2017","journal-title":"Int J Cancer."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa949\/36038668\/dgaa949.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/3\/e1084\/41832846\/dgaa949.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/3\/e1084\/41832846\/dgaa949.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T18:13:10Z","timestamp":1640110390000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/3\/e1084\/6044223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,22]]},"references-count":57,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,12,22]]},"published-print":{"date-parts":[[2021,3,8]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa949","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2020,12,22]]}}}